environmental resistence of mosapride Pages on BioPortfolio:

Results from other life science and pharmaceutical sites:

British Journal of Pharmacology - Inhibition of the human ether-a ...
At least 80% series resistance compensation was achieved in all reported ..... Mosapride, a prokinetic agent with similar pharmacodynamic properties to ...
http://www.nature.com/bjp/journal/v128/n2/full/0702774a.html...

82 selected items - PubMed Results
BACKGROUND AND AIM: Resistance to antibiotics in Helicobacter pylori is .... so opt for combination treatment with prokinetics, mosapride 5 mg tid). ...
http://www.ncbi.nlm.nih.gov/pubmed/18318824,18289353,1817135...

Genetic polymorphisms of human flavin-containing monooxygenase 3 ...
... may cause significant toxicity while low levels may lead to resistance. ..... a gastroprokinetic agent: comparison with cisapride and mosapride citrate.
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22...

News Release
Insulin resistance-decreasing. drug. Diabetes mellitus ... (Mosapride citrate). ＴＡＫ-475. Squalene synthase inhibitor. Hyperlipemia ...
http://www.takeda.com/pdf/usr/default/02072301_26124_3.pdf...

British Journal of Pharmacology - Predicting QT prolongation in ...
Borosilicate glass patch pipettes were pulled to obtain a tip resistance of ...... Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on
...
http://www.nature.com/bjp/journal/v154/n7/full/bjp2008267a.h...

T akeda Chemical Industries, Ltd. 2 0 0 3
Mosapride citrate. Not decided. Not decided. Proton pump inhibitor. LH-RH agonist. Angiotensin II receptor antagonist. Insulin resistance-decreasing drug
...
http://www.takeda.com/pdf/usr/default/ar2003_20641_5.pdf...

Mammalian flavin-containing monooxygenases: structure/function ...
Department of Environmental and Molecular Toxicology and The Linus Pauling ...... a gastroprokinetic agent: comparison with cisapride and mosapride citrate
. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...

Contributes To The Health Of Individuals Worldwide
Once-daily dosing with pioglitazone improves insulin resistance ...... sion of the life-environment business into a wholly owned subsidiary in ...
http://www.takeda.com/pdf/usr/default/ar2004_20468_3.pdf...

Source Subset Code Subset Name Concept Code Source PT Source ...
FDA C54451 Medical Device Problem Codes FDA CDRH C72674 Environmental ...... Identifier Codes Terminology C66204 MOSAPRIDE FDA C63923 FDA Established Names
...
ftp://anonymous@ftp1.nci.nih.gov/pub/cacore/EVS/FDA/FDA_NCIt...

Express Scripts, Inc. 2000 Drug Trend Report
Mosapride and norcisapride are gastric prokinetic agents that are being ...... Partially in response to antibiotic resistance, drug manufacturers are trying
...
http://www.express-scripts.com/industryresearch/industryrepo...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.